Target intelligence / Profile preview

Bacterial 50S ribosomal subunit L11-binding site (50S L11-binding site)

Target
50S L11-binding site
Molecular classification
Ribonucleoprotein, Other
01

Overview

The Bacterial 50S ribosomal subunit L11-binding site is a critical functional region within the large ribosomal subunit, primarily composed of a complex between the 23S ribosomal RNA and the L11 ribosomal protein (Harms et al., 2008, Molecular Cell). This site forms part of the GTPase-associated center (GAC), which is essential for recruiting and activating translational GTPases such as Elongation Factor G (EF-G) and Elongation Factor Tu (EF-Tu) (Voorhees et al., 2010, Science). By facilitating the interaction between these factors and the ribosome, the site plays a pivotal role in the translocation of mRNA and tRNAs during protein synthesis. It is a well-characterized target for thiopeptide antibiotics, such as thiostrepton and micrococcin, which bind at the interface of the rRNA and L11 protein to sterically hinder factor binding (Bagley et al., 2005, Chemical Reviews). Because the structural features of this site are highly conserved across bacterial species but differ significantly from the eukaryotic 60S subunit, it represents a high-affinity target for selective antimicrobial agents. Targeting this secondary site provides an alternative mechanism to traditional antibiotics that focus on the peptidyl transferase center or the nascent peptide exit tunnel.

Other names
Bacterial 50S ribosomal subunit secondary RNA/protein siteGTPase-associated centerGAC23S rRNA-L11 complexThiopeptide binding siteL11-binding domain
02

Mechanism of action

Inhibition of translation elongation by sterically blocking the binding of elongation factors EF-G and EF-Tu to the GTPase-associated center.

03

Biological functions

Protein synthesisTranslation elongationGTPase activationTranslocationOther
04

Disease associations

Infection
05

Safety considerations

Poor aqueous solubility of targeting antibioticsLow bioavailabilityRapid development of resistance via target site modification
06

Interacting drugs

Thiostrepton

4 more in the full profile.

07

Biomarkers

23S rRNA A1067 mutationrplK (L11) mutations23S rRNA methylation status

Beyond the preview

Go deeper on Bacterial 50S ribosomal subunit L11-binding site (50S L11-binding site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 50S ribosomal subunit L11-binding site (50S L11-binding site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call